Last reviewed · How we verify
NCT05410678
Safety And Efficacy Results of Percutaneous Renal Stent Implantation in Ectatic and Aneurysmatic Coronary Arteries
Phase 4 trial testing Renal stent in Coronary Artery Ectasia in 63 participants. Completed in 1 April 2022.
1 January 2022
Quick facts
| Lead sponsor | Bursa Postgraduate Hospital |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 63 |
| Start date | 1 June 2015 |
| Primary completion | 1 January 2022 |
| Estimated completion | 1 April 2022 |
Drugs / interventions tested
- Renal stent — full drug profile →
Conditions studied
- Coronary Artery Ectasia — all drugs for Coronary Artery Ectasia →
Sponsor
Bursa Postgraduate Hospital
Who can join
18 and older, any sex, with Coronary Artery Ectasia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study was to evaluate the efficacy and safety of renal stents implanted in ectatic/aneurysmatic coronary arteries.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Safety and efficacy results of percutaneous renal stent implantation in patients with acute coronary syndrome with ectatic and aneurysmatic coronary arteries.
Çamci S, Ari H, Sünbül A, Ari S, et al · · 2024 · PMID 38299468 · DOI 10.1080/00325481.2024.2313447
Verify or expand the search:
- PubMed search for NCT05410678
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Renal stent
Trials testing the same drug.
- NCT06761378 — Ideal Time of Stenting Prior to Ureteral Access Sheath for Stone Disease · NA · completed
Other recruiting trials for Coronary Artery Ectasia
Currently open trials in the same condition.
- NCT05213429 — Middle East Coronary Artery Ectasia Registry · recruiting
Other Bursa Postgraduate Hospital trials
Trials by the same sponsor.
- NCT07129122 — A Novel Technique for Percutaneous Mitral Paravalvular Leak Closure: LBBAP Lead Assisted Ventricular Septal Way · completed
- NCT06878638 — Nitrate - Clopidogrel - Acute Coronary Syndrome · completed
- NCT06951737 — Evaluation Of The Effect Of SGLT-2 Inhibitors On Atrial Fibrillation Recurrence In Diabetic Patients · completed
- NCT05541757 — Rivaroxaban - Percutaneous Coronary Intervention · completed
- NCT04507282 — Eosinophil and Anticoagulation in COVID-19 Patients · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05410678 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bursa Postgraduate Hospital
- Last refreshed: 8 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05410678.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing